1.	Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000651536, RTOG-0920, NCT00956007
2.	Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer Phase: Phase III Type: Supportive care Status: Approved-not yet active Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000674208, MDA-04-01, 2010-0547, NCT01141231
3.	Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000675520, NCCTG-N09C6, N09C6, NCT01156142
4.	Xerostomia Acupuncture Trial Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2010-0584, NCT01266044
5.	Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Phase: Phase III Type: Supportive care Status: Active Age: 4 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000695718, COG-ACCL1031, ACCL1031, NCT01305200
6.	CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000727295, NCCTG-N11C5, N11C5, NCT01545687
7.	Clobetasol for Oral Graft-Versus-Host Disease Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 12 to 99 Sponsor: NCI Protocol IDs: 120068, 12-C-0068, NCT01557517